Vidafar SRL
3.2 FTEVidafar reported total assets of €2.40m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Mar 2026), with 3.2 full-time equivalents.
The score of Vidafar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +11 % Total assets +165 % Headcount (avg FTE) +39 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Vidafar's annual accounts
Filed annual accounts
- Year ended 31 Aug 2025filed on 30 Mar 2026
- Year ended 31 Aug 2024filed on 28 Mar 2025
- Year ended 31 Aug 2023filed on 22 Apr 2024
- Year ended 31 Aug 2022filed on 31 Mar 2023
- Year ended 31 Aug 2021filed on 31 Mar 2022
Vidafar's financial analysis
- Solvency30.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Vidafar
Vidafar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0422.445.391
- VAT number
- BE0422445391
- Peppol
- Registered · 0208:0422445391 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Feb 1982
- Registered office
- 9850 Deinze
- Size
- Micro · 3.2 FTE
- Latest accounts
- 2025 · filed on 30 Mar 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Vidafar (SRL) has been based in Deinze since 1982, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 5,686 € and equity of 741,205 €; its revenue is not published. With 3.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 30.9%, below the median of its sector (44.2%).
Companies similar to Vidafar
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Monnens Retail sale of pharmaceutical products Maaseik · balance sheet €2.41m
- Pharmacie Voss-Richard Retail sale of pharmaceutical products Verlaine · balance sheet €2.38m
- Vinvest Retail sale of pharmaceutical products Edegem · balance sheet €2.43m
- Extrapharm HUY Retail sale of pharmaceutical products Huy · balance sheet €2.43m
- Pharma Guillaume Retail sale of pharmaceutical products Ciney · balance sheet €2.35m
- Holsbeek Brecht - Sint -Lenaerts Retail sale of pharmaceutical products Brecht · balance sheet €2.44m
- Pharmacerto Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €2.34m
- Hoffmann Apotheek Retail sale of pharmaceutical products Keerbergen · balance sheet €2.34m
Frequently asked questions about Vidafar
What is the revenue of Vidafar?
Vidafar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Vidafar?
In Belgium, the VAT number is the company number prefixed with BE: BE0422445391 for Vidafar, if the company is VAT-registered. Its company number (CBE) is 0422.445.391.
Where is the registered office of Vidafar?
According to the CBE register, the registered office of Vidafar is in 9850 Deinze.
What is the equity of Vidafar?
At the close of the 2025 financial year, the equity of Vidafar amounts to 741,205 €, a solvency of 30.9% of total assets.
How many people work at Vidafar?
3.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Vidafar?
The register lists 3 active mandates at Vidafar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Vidafar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →